Psoriasis trials in Canada

In Canada 19 Also abroad 274

19 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Saskatoon, Sherbrooke, Trois-Rivières
Age
18 years and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
Phase 2Not yet taking people in Canada
A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis
Where
Markham, Mississauga, Peterborough, Québec, Richmond Hill, Saskatoon
Age
18 years to 70 years
People
100
Run by
Coultreon Biopharma
See details and how to joinNCT07914231 · EU 2026-527405-38-00
No phaseTaking people
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Where
Montreal
Age
18 years and over
People
500
Run by
Innovaderm Research Inc.
See details and how to joinNCT05994976
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Ajax, Barrie, Calgary, Edmonton, Hamilton, Kelowna, London, Markham, Mississauga, Montreal, Nanaimo, Newmarket, North Bay, Oakville, Ottawa, Peterborough, Québec, Richmond Hill, Sherbrooke, St. John's, Surrey, Toronto, Verdun, Winnipeg
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Edmonton, London, Montreal, Richmond Hill, St. John's, Toronto, Winnipeg
Age
12 years to 17 years
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Calgary, Edmonton, Hamilton, Markham, Toronto
Age
4 years to 18 years
People
153 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00
Phase 2Taking people
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Where
Ajax, Edmonton, Fredericton, London, Markham, Montreal, Peterborough, Québec, Surrey, Toronto, Waterloo
Age
18 years and over
People
240 worldwide
Run by
Oruka Therapeutics, Inc.
See details and how to joinNCT07449702 · EU 2026-526898-42-00
No phaseTaking people
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Where
Calgary, Halifax, Toronto, Winnipeg
Age
Up to 21 years
People
20,000 worldwide
Run by
Duke University
See details and how to joinNCT02418442
Phase 1Taking people
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Where
Toronto
Age
18 years and over
People
300 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03816345
No phaseTaking people
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Where
Ajax, Belleville, Calgary, Edmonton, Hamilton, London, Markham, Oakville, Ottawa, Peterborough, Saint-Jérôme, Thunder Bay, Toronto, Whitby, Winnipeg
Age
18 years and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT07039110
No phaseTaking people
Modifying PEST for Psoriatic Arthritis Screening
Where
Barrie, Calgary, Edmonton, Fredericton, Greater Sudbury, Hamilton, Kelowna, London, Markham, Montreal, Ottawa, Québec, Richmond Hill, Saskatoon, Ste-Foy, Stoney Creek, Surrey, Toronto, Verdun, Waterloo, Winnipeg
Age
18 years and over
People
502
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06382051
Phase 1Taking people
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Where
Calgary, Vancouver
Age
18 years and over
People
20 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00
No phaseTaking people
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Where
Burlington, Hamilton, Kanata, Ottawa, Pickering, Saskatoon
Age
18 years and over
People
80
Run by
Chronicle Academy
See details and how to joinNCT07370766
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Calgary, Toronto, Vancouver
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
Phase 4Taking people
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Where
Ottawa, Québec
Age
18 years and over
People
100 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00
Phase 4Taking people
Multi-Center PAMPA Study
Where
St. John's, Toronto
Age
18 years and over
People
176 worldwide
Run by
NYU Langone Health
See details and how to joinNCT05004727
No phaseTaking people
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Where
Toronto
Age
18 years and over
People
500
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07298265
No phaseNot yet taking people in Canada
Personalized Outreach for Equitable Treatment in Rheumatology
Where
Vancouver
Age
18 years and over
People
20
Run by
University of British Columbia
See details and how to joinNCT07022756
No phaseTaking people
Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
Where
Toronto
Age
18 years and over
People
540
Run by
Women's College Hospital
See details and how to joinNCT05954364